Shared FUSMobile
The Neurolyser Was Granted CE Mark
FUSMobile has announced that its Neurolyser XR device has been granted CE Mark for the treatment of lumbar zygapophyseal joints...
top of page
Shared FUSMobile
Oct 18
Sacroiliitis study opens in UVA
The first few participants have been enrolled in a new clinical trial investigating the safety and efficacy of using FUSMobile’s...
0
Shared FUSMobile
Jun 18
Company Profile: FUSMobile
In 2014, FUSMobile co-founders Arik Hananel, MD, and Ron Aginsky, LLB, MBA, identified a need for a compact, mobile, and user-friendly...
0
Shared FUSMobile
Jun 18
High Intensity Focused Ultrasound: A novel and non-invasive approach to target tumors
Use of High Intensity Focused Ultrasound (HIFU) has been lauded as an incredible therapeutic alternative for tumors, pain and other...
0
bottom of page